Brio Consultants
PFE icon

Brio Consultants’s Pfizer PFE Stock Holding History

Brio Consultants’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$205K Buy
+7,178
New +$191K 0.02% 170

Other funds holding PFE

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $296B AUM 23.14% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $142B AUM 43.93% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return

Brio Consultants's PFE Position: Q3 2026 in Review

Brio Consultants opened a new position in Pfizer (PFE) in Q3 2026: 7,178 shares worth $205K. The stake represents 0.02% of the portfolio and ranks #170 among its holdings.

2,556 funds tracked by Wall St. Rank hold PFE as of Q3 2026.

  • Brio Consultants held 7,178 shares of Pfizer worth $205K as of Q3 2026.
  • Pfizer was a new Brio Consultants position in Q3 2026.
  • Pfizer made up 0.02% of Brio Consultants's portfolio in Q3 2026, its #170 holding.
  • 2,556 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.

Based on Brio Consultants's 13F filing for Q3 2026, filed 13 Nov 2026.